C5's 4th Annual Conference on 'Pharma & Biotech Patent Litigation'
Event | 01.31.12 - 02.01.12, 12:00 AM UTC - 12:00 AM UTC
C5’s 4th Annual Forum on Pharma & Biotech Patent Litigation brings together key regulators and judicial authorities, distinguished in-house counsel from the world’s largest pharma and biotech companies, and their expert legal advisors from across Europe and the US. Based on their first-hand experience in recent pharma and biotech patent litigation, the expert panel will provide you with important case law updates and invaluable strategies to combat the latest challenges.
Sean-Paul Brankin will speak on "Disclosure of Prior Art and Forthcoming Antitrust Issues."
Insights
Event | 02.20.25
Has the Buss Stopped? Recoupment Today
Has the Buss Stopped? Recoupment Today: In 1997, the California Supreme Court decided Buss v. Superior Court. In Buss, the court concluded that a liability insurer that defended a mixed action could seek reimbursement from the insured for the defense costs associated with the claims that were not even potentially covered. Since then, numerous courts have held that insurers are entitled to recoup their defense costs associated with uncovered claims or causes of action. On the other hand, a significant number of courts have rejected insurers’ right to recoupment, at least in the absence of a policy provision granting the insurer that right. Some commentators have even suggested that the current judicial trend might be away from permitting insurers to recoup their defense costs. Is that correct? Has the Buss stopped? This panel of coverage experts will analyze insurers’ claimed right to recoupment today, and offer their perspectives on what the law on recoupment should perhaps be and might be in the future.
Event | 12.05.24
Event | 12.05.24
Event | 12.04.24
Inside the Arbitrators’ Chambers: Best Practices of Arbitrators